BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25704956)

  • 1. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.
    Kravchenko J; Berry M; Arbeev K; Lyerly HK; Yashin A; Akushevich I
    Lung Cancer; 2015 Apr; 88(1):85-93. PubMed ID: 25704956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.
    Driessen EJM; Schulkes KJG; Dingemans AC; van Loon JGM; Hamaker ME; Aarts MJ; Janssen-Heijnen MLG
    Lung Cancer; 2018 Feb; 116():55-61. PubMed ID: 29413051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular comorbidities and their prognostic value in small cell lung cancer patients with chemoradiotherapy.
    Liang H; Wang T; Liu D; Wang H; Ba Z; Xiao Y; Liu Y; Yuan J; Yang W
    Clin Transl Oncol; 2024 Jun; 26(6):1348-1356. PubMed ID: 38103121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.
    Langer C; Ravelo A; Hazard SJ; Guerin A; Ionescu-Ittu R; Latremouille-Viau D; Wu EQ; Ramalingam S
    Lung Cancer; 2014 Dec; 86(3):350-7. PubMed ID: 25439437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of statins on survival in patients with stage IV lung cancer.
    Lin JJ; Ezer N; Sigel K; Mhango G; Wisnivesky JP
    Lung Cancer; 2016 Sep; 99():137-42. PubMed ID: 27565929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
    Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
    BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
    Zell JA; Ou SH; Ziogas A; Anton-Culver H
    Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer.
    Sun JY; Zhang ZY; Qu Q; Wang N; Zhang YM; Miao LF; Wang J; Wu LD; Liu Y; Zhang CY; Wang RX
    Int J Cardiol; 2021 May; 330():186-193. PubMed ID: 33581175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive treatment patterns and survival in stage II non-small cell lung cancer.
    Yan SX; Qureshi MM; Suzuki K; Dyer M; Truong MT; Litle V; Mak KS
    Lung Cancer; 2018 Oct; 124():135-142. PubMed ID: 30268452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Arunachalam A; Li H; Bittoni MA; Camacho R; Cao X; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e783-e799. PubMed ID: 29983370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
    Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
    Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.